Literature DB >> 17222956

Truncations of gelonin lead to a reduction in its cytotoxicity.

Zhuoyu Li1, Yanfeng Qu, Hanqing Li, Jingming Yuan.   

Abstract

Gelonin is a single chain ribosome-inactivating protein (RIP) with potential applications as a bullet of immunoconjugate for the treatment of cancer and AIDS. Using truncated forms of gelonin, we now report the relationship between its conformation and function. Circular dichroism (CD) and fluorescence spectra show that the N-terminus forms beta-sheets whereas the C-terminus contains alpha-helices of secondary structures. Biological experiments indicate that all gelonin truncation mutants lose partial toxicity compared to intact gelonin, an effect most strongly seen with C-terminally truncated gelonin. Similar evidence is also provided using a DNase-like activity assay. In addition, the intact gelonin exhibits the highest cytotoxicity to cancer cells. These results suggest that truncations of the terminal region of gelonin negatively regulate its function dominantly and that, due to its toxicity, intact gelonin is an important potential immunoconjugate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17222956     DOI: 10.1016/j.tox.2006.11.074

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

Review 2.  Toxic proteins application in cancer therapy.

Authors:  Zahra Setayesh-Mehr; Mahdiye Poorsargol
Journal:  Mol Biol Rep       Date:  2021-04-25       Impact factor: 2.316

3.  Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.

Authors:  Petra Kornberger; Arne Skerra
Journal:  MAbs       Date:  2013-12-09       Impact factor: 5.857

4.  Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.

Authors:  Meong Cheol Shin; Jingwen Zhao; Jian Zhang; Yongzhuo Huang; Huining He; Mei Wang; Kyoung Ah Min; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2014-04-23       Impact factor: 4.396

5.  Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity.

Authors:  Meong Cheol Shin; Jian Zhang; Allan E David; Wolfgang E Trommer; Young Min Kwon; Kyoung Ah Min; Jin H Kim; Victor C Yang
Journal:  J Control Release       Date:  2013-08-23       Impact factor: 9.776

6.  A Spectroscopic Study on Secondary Structure and Thermal Unfolding of the Plant Toxin Gelonin Confirms Some Typical Structural Characteristics and Unravels the Sequence of Thermal Unfolding Events.

Authors:  Andrea Scirè; Fabio Tanfani; Alessio Ausili
Journal:  Toxins (Basel)       Date:  2019-08-22       Impact factor: 4.546

7.  Molecularly engineered tumor acidity-responsive plant toxin gelonin for safe and efficient cancer therapy.

Authors:  Guo-Bin Ding; Chenchen Zhu; Qian Wang; Huiyan Cao; Bin-Chun Li; Peng Yang; Roland H Stauber; Guangjun Nie; Zhuoyu Li
Journal:  Bioact Mater       Date:  2022-02-11

8.  Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles.

Authors:  Xingfang Su; Nicole Yang; K Dane Wittrup; Darrell J Irvine
Journal:  Biomacromolecules       Date:  2013-03-11       Impact factor: 6.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.